References
- Aguglia U., Zappia M., Quattrone A. Carbamazepine-induced nonepileptic myoclonus in a child with benign epilepsy. Epilepsia 1987; 28(5)515–518
- Asconapè J. J., Manning K. R., Lancman M. E. Systemic lupus erythematosus associated with use of valproate. Epilepsia 1994; 35(1)162–163
- Bleck T. P., Smith M. C. Possible induction of systemic lupus erythematosus by valproate. Epilepsia 1990; 31(3)343–345
- Commission on Classification and Terminology. International League Against Epilepsy: Proposal for classification of epilepsies and epileptic syndromes. Epilepsia 1985; 26: 268–78
- Coope R., Burrows R. G. R. Treatment of epilepsy with sodium diphenyl hydantoinate. Lancet 1940; 1: 490–492
- Dhuna A., Pascual-Leone A., Talwar D. Exacerbation of partial seizures and onset of nonepileptic myoclonus with carbamazepine. Epilepsia 1991; 32(2)275–278
- Dreifuss F. E. Classification of epileptic seizures and the epilepasies. Pediatrics Clinical North America 1989; 36: 265–279
- Harris D. W. S., Ostlere L., Buckley C., Whittaker S., Sweny P., Rustin M. H. A. Phenytoin-induced pseudolymphoma. A report of a case and review of the literature. British Journal of Dermatology 1992; 127: 403–406
- Kanno T., Miyata M., Kazuta Y., Sato Y., Nishimaki T., Kasukawa R. Carbamazepineinduced systemic lupus erythematosus-like disease. Intern-Med 1992; 31(11)1303–1305
- Kruger G. R. F., Harris D. Is phenytoin carcinogenetic?. Lancet 1972; 1: 323
- Marciani M. G., Maschio M. C. D., Spanedda F., Iani C., Gigli G. L., Bernardi G. Development of myoclonus in patients with partial epilepsy during treatment with vigabatrin: an electroencephalografic study. Acta Neurologica Scandinavica 1994; 91: 1–5
- Saltzstein S. L., Ackerman L. V. Lymphadenopathy induced by anticonvulsant drugs and mimicking clinically and pathologically malignant lymphomas. Cancer 1959; 12: 164–182
- Shields W. D., Saslow E. Myoclonic, atonic, and absence seizures following institution of carbamazepine therapy in children. Neurology 1983; 33: 1487–1489
- Singsen B. H., Fishman L., Hanson V. Antinuclear antibodies and lupus-like syndromes in children receiving anticonvulsants. Pediatrics 1976; 57: 529–534
- Speirs C., Fielder A. H., Chapel H., Davey N. J., Batchelor J. R. Complement system protein C4 and susceptibility to hidralazine-induced systemic lupus erythematosus. Lancet 1989; 1(8644)922–924
- Talwar D., Arora M. S., Sher P. K. EEG changes and seizure exacerbation in young children treated with carbamazepine. Epilepsia 1994; 35(6)1154–1159
- Teoh P. C., Chan H. L. Lupus-scleroderma syndrome induced by ethosuximide. Archives Diseases of Children 1975; 50: 658–661
- Wendland K. L. Myoklonien nach gaben von carbamazepin. Nervenarzt 1968; 39: 231–233
- Yung R. L., Richardson B. C. Drug-induced lupus. Rheum Diseases of Clin North America 1994; 20: 61–86